Immunocapture assay for cancer procoagulant antibody complex in biological samples
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Feb 11, 1997
Issued Date -
N/A
app pub date -
May 20, 1994
filing date -
Jul 2, 1987
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
This invention provides a specific immunocapture ELISA for the quantitation of cancer procoagulant antibody complex (CPAC) in biological samples. In particular, this invention provides methods and techniques for specifically selecting and quantitatively measuring CPAC from a sample material using anti-CP antibodies followed by labeled anti-immunoglobulin antibodies. The amount of captured CPAC is then determined by measuring the amount of label in the captured CPAC.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully